CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset

Autor: Christiane Gog, Murielle Mauer, Markus Moehler, C. Koehne, Daniela E. Aust, Arndt Weinmann, Manfred P. Lutz, Thomas Schmitt, Erik Tanis, Thomas Thomaidis, Felicitas Roelofson, Frederic Fiteni, Annett Maderer

Publikováno v: Acta Oncologica. 60:1543-1547

Adjuvant colon cancer (CC) therapy and survival have greatly evolved over the last decades. Research shifted towards a more biological tumour understanding and unlocked new therapies and disease mo...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::32f06dba01dbbbd16b155d175408dc68
https://doi.org/10.1080/0284186x.2021.1959057

SOP – Behandlung und Betreuung in der Sterbephase

Autor: Thomas Montag, Christoph Ostgathe, Michael Thomas, Barbara Starbatty, Steffen T. Simon, Christiane Gog

Publikováno v: Der Onkologe. 23:385-388

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6d7c416f9ef65e904c6a9a6dcc4e40b
https://doi.org/10.1007/s00761-017-0213-y

Intraperitoneal bevacizumab for control of malignant ascites due to advanced-stage gastrointestinal cancers: A multicentre double-blind, placebo-controlled phase II study - AIO SUP-0108

Autor: Michael Stahl, Djordje Atanackovic, Dirk Arnold, Tim Luetkens, Karin Jordan, Axel Hinke, W. Freier, Susanna Hegewisch-Becker, Christiane Gog, B. Killing, Jörn Rüssel

Publikováno v: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP

Purpose Malignant ascites is debilitating for patients with advanced cancer. As shown previously, tumour cell production of vascular endothelial growth factor might be a major cause of the formation of malignant ascites. Intraperitoneal bevacizumab c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8e92df64e38823297d3ddf4f13d4bfb
https://hdl.handle.net/10400.26/14158

Prospective Pilot Study of Neoadjuvant Chemotherapy with 5-Fluorouracil, Folinic Acid and Oxaliplatin in Resectable Liver Metastases of Colorectal Cancer. Analysis of 42 Neoadjuvant Chemotherapies*

Autor: W. Padberg, Hans-Helge Müller, E. Staib-Sebler, Christiane Gog, Matthias W. Lorenz, D. Proschek, Karsten Ridwelski, Karl-Walter Jauch, Karin Zamzow, Ute Lehmann, K.-H. Vestweber, Werner Hohenberger, Heinz-Jochen Gassel

Publikováno v: Zentralblatt für Chirurgie. 128:87-94

Purpose: Since there are currently no data available from a prospective trial, the primary objective of this prospective study was to investigate whether the rate of RO-liver resections without morbidity would be at least 50% in patients with neoadju

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73a9c40b8c09108f90db3aa67051bf5e
https://doi.org/10.1055/s-2003-37760

Die Stellung der regionalen Langzeitchemotherapie bei Lebermetastasen

Autor: Gregor Vetter, M. Lorenz, Hans-Helge Müller, H. Petrowsky, E. Staib-Sebler, Christiane Gog

Publikováno v: Der Chirurg. 70:141-153

Eine Metastasierung kann bei zahlreichen Tumoren zunachst auf die Leber beschrankt sein. Bei nichtresektablen Befunden wurden zahlreiche regionale Therapiemodalitaten insbesondere die intraarterielle (i.a.) Chemotherapie vorteilhafter als eine system

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d7e7dce728e0c9909aa229ff2f3a704f
https://doi.org/10.1007/s001040050061